ReleaseWire Connect

Clinical trial report, Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014" provides data on the Polymyalgia Rheumatica clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polymyalgia Rheumatica. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polymyalgia Rheumatica. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

clinical trial report, Insomnia Global Clinical Trials Review, H2, 2014" provides data on the Insomnia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Insomnia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Insomnia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Clinical trial report, Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014" provides data on the Intracerebral Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracerebral Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intracerebral Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, Intracranial Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Intracranial Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracranial Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intracranial Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Clinical trial report, Myoclonic Seizures Global Clinical Trials Review, H2, 2014" provides data on the Myoclonic Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonic Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonic Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neonatal Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The latest report from GlobalData, Emerging Nuclear Power Countries Market Forecast, Key Companies and Development Analysis to 2030 covers the emerging nuclear market and the key factors affecting demand. It also provides comprehensive information on key market players and their global market share. The market value for upcoming reactors in various countries across the world has also been estimated.

GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape United Arab Emirates. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the UAE, identifying key trends in its healthcare market and providing insights into its demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.

Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including fevers, retro-orbital pain, severe headache, muscle and joint pain, and rash. The severity of dengue fever ranges from asymptomatic cases, to classic dengue fever, and to dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS) that have a mortality rate of 5%-15%.

China’s aquaculture crop maintained steady growth during 2007-2012, with that of Seawater Aquaculture products and freshwater aquaculture products recording a CAGR of about 4.7% and 6.1%, respectively. In 2013, China’s aquaculture crop saw a year on year rise of 5.9% and reached 45.4168 million tons. The middle and high-end products like abalone, sea cucumber, white shrimp and tilapia developed rapidly, wherein the crop of abalone and sea cucumber achieved a CAGR of above 10% each over the past five years. With advancement of aquaculture technologies and improvement of people’s consumption level, it is expected that China’s aquaculture area and crop will keep a rapid growth rate during 2014-2017.